PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Sergiu P. Paşca receives the 2024 ISSCR Momentum Award for his pioneering work in neurodevelopment and disease

Sergiu P. Paşca receives the 2024 ISSCR Momentum Award for his pioneering work in neurodevelopment and disease
2024-02-06
(Press-News.org) Evanston, IL— The International Society for Stem Cell Research (ISSCR) will present this year’s ISSCR Momentum Award to Sergiu P. Paşca, M.D., Kenneth T. Norris, Jr. Professor and the Uytengsu Director of Stanford Brain Organogenesis, Stanford University, U.S.A. The award recognizes the exceptional achievements of a mid-career investigator whose innovative research has established a major area of stem cell-related research with a strong trajectory for future success.

Dr. Paşca will present his research during Plenary VII on 13 July 2024 during the ISSCR 2024 Annual Meeting in Hamburg, Germany. ISSCR 2024 is the world’s leading gathering of the brightest minds in stem cell research and regenerative medicine.

“Dr. Pașca’s visionary work has given the scientific community unprecedented insights into neurodevelopment and disease,” ISSCR President Amander Clark, Ph.D., said. “His groundbreaking contributions have transformed the way stem cells are used to tackle questions in neuroscience and reveal the power of molecular psychiatry. Congratulations Sergiu on earning this well-deserved recognition.”

“Receiving the ISSCR Momentum Award is a tremendous honor and one that would not have been possible without the dedication of both current and past members of the lab,” Dr. Pașca said. “This recognition of our work in developing assembloids and organoids for neuroscience is a testament to a collaborative spirit and a strong desire to decipher how the human nervous system assembles itself. We are living in an exciting time for human neuroscience, and my team and I at Stanford remain more committed than ever to applying the tools we have developed to develop therapeutics for devastating neuropsychiatric disorders.”

Sergiu P. Paşca seeks to understand the rules governing human brain assembly and the mechanisms of disease. His laboratory pioneered assembloids, introduced the use of instructive signals to create regionalized neural organoids, and developed integrated human circuits following transplantation. These models have been adopted by hundreds of laboratories worldwide, and Dr. Paşca systematically applied them to gain insights into physiology and disease and to develop therapeutic approaches.

He was named a New York Times’ Visionary in Medicine and Science. He is a Knight of the Order of Merit, holds a Doctor Honoris Causa, and was a TED-2022 speaker. His work was recognized with the Vilcek Prize, the American Philosophical Society's Judson Daland Prize, the Daniel E. Efron Award, the Altman Award for Developmental Neuroscience, the Gunther Blobel Award for Cell Biology, the AE Bennett Award in Biological Psychiatry, and the IBRO-Kemali Neuroscience Award.

ISSCR 2024, co-sponsored by the City of Hamburg, Life Science Nord, Bayer, and BlueRock Therapeutics, will take place 10-13 July 2024 in Hamburg, Germany.

About the International Society for Stem Cell Research (www.isscr.org)
With nearly 5,000 members from 80 countries, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health. Additional information about stem cell science is available at AboutStemCells.org, an initiative of the Society to inform the public about stem cell research and its potential to improve human health.

###

END


[Attachments] See images for this press release:
Sergiu P. Paşca receives the 2024 ISSCR Momentum Award for his pioneering work in neurodevelopment and disease Sergiu P. Paşca receives the 2024 ISSCR Momentum Award for his pioneering work in neurodevelopment and disease 2

ELSE PRESS RELEASES FROM THIS DATE:

Understanding neurodiversity across the UK population - study

2024-02-06
A new study has provided insight into how experiences and features of neurodiversity vary amongst adults in the UK. There is variation in people’s attributes and experiences across all populations. Neurodivergent people, such as people with a diagnosis of ADHD, dyslexia, dyspraxia, or autism, may experience the world in distinctive ways. But, we are only beginning to appreciate how traits and experiences associated with neurodivergence differ across the whole population. Now, new research from the University of Birmingham has provided a more detailed picture of what neurodiversity looks like amongst adults in the UK. The research is published in JCPP Advances. Ian Apperly, ...

A new origin story for deadly Seattle fault

A new origin story for deadly Seattle fault
2024-02-06
American Geophysical Union 6 February 2024 AGU Release No. 24-04 For Immediate Release This press release is available online at: https://news.agu.org/press-release/seattle-fault-may-have-origins-in-an-ancient-tear-in-the-continent Seattle fault may have origins in an ancient tear in the continent Magnetic data suggest the hazardous Seattle fault zone developed as the edge of the continent tore itself in two more than 50 million years ago, providing a possible new origin story for the fault AGU ...

Which came first: Black holes or galaxies?

Which came first: Black holes or galaxies?
2024-02-06
Black holes not only existed at the dawn of time, they birthed new stars and supercharged galaxy formation, a new analysis of James Webb Space Telescope data suggests. The insights upend theories of how black holes shape the cosmos, challenging classical understanding that they formed after the first stars and galaxies emerged. Instead, black holes might have dramatically accelerated the birth of new stars during the first 50 million years of the universe, a fleeting period within its 13.8 billion—year history. "We know these monster black holes ...

Wang studying learning coordination for Multi-Autonomous Multi-Human (MAMH) agent systems with guaranteed safety

2024-02-06
Xuan Wang, Assistant Professor, Electrical and Computer Engineering, is designing a framework for Multi-Autonomous Multi-Human (MAMH) systems.  The operation of many real-world systems involves the co-existence of human and autonomous agents. Inadequate coordination among these agents can lead to significant performance degradation or safety risks.   In this project, Wang aims to develop a novel framework for Multi-Autonomous Multi-Human coordination, which could enhance algorithmic scalability and ...

Doctors have more difficulty diagnosing disease when looking at images of darker skin

2024-02-06
CAMBRIDGE, MA -- When diagnosing skin diseases based solely on images of a patient’s skin, doctors do not perform as well when the patient has darker skin, according to a new study from MIT researchers. The study, which included more than 1,000 dermatologists and general practitioners, found that dermatologists accurately characterized about 38 percent of the images they saw, but only 34 percent of those that showed darker skin. General practitioners, who were less accurate overall, showed a similar decrease in accuracy ...

Vilcek Foundation awards $250,000 to immigrant scientists

Vilcek Foundation awards $250,000 to immigrant scientists
2024-02-06
The Vilcek Foundation announces the recipients of the 2024 Vilcek Foundation Prizes in Biomedical Science. Awarded annually since 2006, the prizes recognize outstanding immigrant scientists at the forefront of their fields, and celebrate the importance of immigrant contributions to scientific research and discovery in the United States. In 2024, the foundation awards $250,000 in prizes to Luciano Marraffini (b. Argentina), Gerta Hoxhaj (b. Albania), Tomasz Nowakowski (b. Poland) and Takanori Takebe (b. Japan). “With the 2024 Vilcek Foundation Prizes in Biomedical Science, we honor scientists who have ...

Covid vaccine for pregnant women safe for newborn infants

Covid vaccine for pregnant women safe for newborn infants
2024-02-06
No increased risks for babies, and for some serious neonatal complications lower risks. This is the result of the largest study to date on the safety of newborn babies whose mothers were vaccinated against COVID-19 during pregnancy. The study is a collaboration between Swedish and Norwegian researchers and is published in the journal JAMA. COVID-19 vaccination in pregnancy was not associated with any increased risks in newborn infants. On the contrary, the study of nearly 200,000 newborns in Sweden and Norway showed that babies born by women who chose to be vaccinated ...

Neonatal outcomes after COVID-19 vaccination in pregnancy

2024-02-06
About The Study: In this population-based study from Sweden and Norway that included 94,000 infants exposed to COVID-19 vaccination during pregnancy and 102,000 control infants born between June 2021 and January 2023, vaccination of pregnant individuals with mRNA COVID-19 vaccines was not associated with increased risks of neonatal adverse events in their infants.  Authors: Mikael Norman, M.D., Ph.D., of the Karolinska Institutet in Stockholm, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2023.26945) Editor’s Note: Please ...

Effectiveness of bivalent mRNA COVID-19 vaccines in preventing SARS-CoV-2 infection in children and adolescents ages 5 to 17

2024-02-06
About The Study: The bivalent COVID-19 vaccines protected children and adolescents against SARS-CoV-2 infection and symptomatic COVID-19 in this study including 2,959 participants ages 5 to 17 years. These data demonstrate the benefit of COVID-19 vaccine in children and adolescents. All eligible children and adolescents should remain up to date with recommended COVID-19 vaccinations.  Authors: Leora R. Feldstein, Ph.D., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author. To access the embargoed study: Visit our For The Media website ...

Pancreatic Cancer: Italian scientists found out how the tumor escapes therapies

2024-02-06
Italian scientists from Università Cattolica at Rome discovered an important genetic mechanism that pancreatic cancer cells employ to evade therapies, paving the way to new drugs for a killer disease. The tumor evades treatments by implementing a 'favorable genetic reshuffling,' strategically playing its best cards to thwart cures. This finding is the result of a study published today in the journal Cell Reports Medicine, coordinated by Claudio Sette, Professor of Human Anatomy at the Catholic University, and Director of the "Organoids Facility" at the Policlinico Universitario A. Gemelli ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Sergiu P. Paşca receives the 2024 ISSCR Momentum Award for his pioneering work in neurodevelopment and disease